AI has all but overtaken the thinking universe. Training an early version of ChatGPT consumes about 1300 megawatt-hours of ...
SEONGNAM, South Korea, April 6, 2025 /PRNewswire/ -- ABL Bio Inc. (KOSDAQ: 298380), a clinical-stage biotech company developing bispecific antibody technology for immuno-oncology and neurodegenerative ...
BrainChild Bio advancing BCB-276 towards BLA submission with a single pivotal Phase 2 trial planned to commence in Q4 2025 SEATTLE & CAMBRIDGE, Mass.--(BUSINESS WIRE)--BrainChild Bio, Inc., a clinical ...
JuneBrain Inc., a Baltimore-based neurotech startup, took first place at the 2025 BioChallenge Pitch Competition, held October 30 at the New Orleans BioInnovation Center (NOBIC). The annual contest ...
PHILADELPHIA--(BUSINESS WIRE)--Latus Bio, Inc. (Latus), a biotechnology company pioneering advances in AAV gene therapy, has announced new research published today in Science Translational Medicine, ...
A new spatial transcriptomic approach captures the regulation of splicing and polyadenylation sites during pubescent brain development at near-single-cell resolution. An international collaboration, ...
Manifold Biotechnologies Inc. has signed a strategic research collaboration and license agreement with F. Hoffmann-La Roche Ltd. to develop next-generation brain shuttles for neurological diseases.
Scientists placed 200,000 living human brain cells on a microchip and taught it how to play a doomsday video game — and are now using the dystopian tech to power AI data centers. Australian biotech ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results